Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021

Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021

Related Keywords

United States ,America ,American ,Isabella Zinck ,Jay Bradner ,Ianw Flinn ,Thomas Hungerbuehler ,Samir Shah ,Parag Mahanti ,Julie Masow ,Sloan Simpson ,Alina Levchuk ,Fiona Phillips ,Novartis Institutes For Biomedical Research ,Twitter ,Novartis Oncology Communications ,Novartis Us External Communications ,Novartis External Communications ,Novartis ,Exchange Commission ,American Society Of Hematology ,American Society Of Hematology Annual Meeting Exposition ,American Society ,Hematology Annual Meeting ,Novartis Institutes ,Lymphoma Research Program ,Sarah Cannon Research Institute ,Biomedical Research ,Novartist Charge ,Oncology Cell Therapy ,First In Human Study ,Novelt Charge ,Diffuse Largeb Cell Lymphoma ,Oral Presentation ,Annual Meeting ,Fully Human ,Refractory Multiple Myeloma Manufactured ,Novartis Media ,Investegate Announcements ,Investegate Company Announcements ,Ovartis Ag Chf0 50 Regd ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,